Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,323 papers from all fields of science
Search
Sign In
Create Free Account
glycosphingolipid metabolic process
Known as:
glycosphingolipid metabolism
The chemical reactions and pathways involving glycosphingolipids, any compound with residues of sphingoid and at least one monosaccharide. [ISBN…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
No difference in glycosphingolipid metabolism and mitochondrial function in glucocorticoid-induced insulin resistance in healthy men.
M. Brands
,
D. H. Raalte
,
+5 authors
M. Serlie
Journal of Clinical Endocrinology and Metabolism
2013
Corpus ID: 5572575
OBJECTIVE Glucocorticoids (GCs) are well known to induce insulin resistance; however, mechanisms that cause the impairement of…
Expand
Review
2012
Review
2012
Fabry International Prognostic Index: a predictive severity score for Anderson-Fabry disease
D. Hughes
,
M. Malmenäs
,
+9 authors
C. Jenkinson
Journal of Medical Genetics
2012
Corpus ID: 22418124
Background Anderson-Fabry disease (AFD) is a disorder of glycosphingolipid metabolism resulting from deficiency of…
Expand
Review
2011
Review
2011
Sphingolipid metabolism and drug resistance in hematological malignancies.
Valérie Gouazé-Andersson
,
M. Cabot
Anti-Cancer Agents in Medicinal Chemistry
2011
Corpus ID: 23445029
Drug resistance represents a serious barrier to the successful treatment of hematological malignancies. In leukemias, resistance…
Expand
2009
2009
Proteomic analysis of enriched lysosomes at early phase of camptothecin-induced apoptosis in human U-937 cells.
N. Parent
,
E. Winstall
,
M. Beauchemin
,
C. Paquet
,
G. Poirier
,
R. Bertrand
Journal of Proteomics
2009
Corpus ID: 26089470
Review
1999
Review
1999
Recent advances in the biochemistry of glycosphingolipid metabolism.
T. Kolter
,
T. Doering
,
G. Wilkening
,
N. Werth
,
K. Sandhoff
Biochemical Society Transactions
1999
Corpus ID: 44995829
1991
1991
Fabry disease in a large Nova Scotia kindred: carrier detection using leucocyte alpha-galactosidase activity and an NcoI polymorphism detected by an alpha-galactosidase cDNA clone.
A. J. Kirkilionis
,
D. Riddell
,
M. W. Spence
,
R. Fenwick
Journal of Medical Genetics
1991
Corpus ID: 11005723
Fabry disease is an X linked recessive disorder of glycosphingolipid metabolism resulting from a deficiency of the lysosomal…
Expand
1990
1990
Abnormal glycosphingolipid metabolism in the nervous system of galactosialidosis
H. Yoshino
,
K. Miyashita
,
+8 authors
T. Miyatake
Journal of Neurological Sciences
1990
Corpus ID: 33765825
1988
1988
Cardiovascular Manifestations in Fabry's Disease — Age‐Related Changes in Hemizygotes and Heterozygotes —
Y. Yanagawa
,
H. Sakuraba
Acta paediatrica Japonica : Overseas edition
1988
Corpus ID: 38420939
Fabry's disease is an X‐linked recessive disorder of glycosphingolipid metabolism. Accumulation of neutral sphingolipid in…
Expand
1983
1983
Amiodarone phenocopy of Fabry's keratopathy.
C. Whitley
,
M. Tsai
,
J. Heger
,
E. Prystowsky
,
D. Zipes
Journal of the American Medical Association (JAMA…
1983
Corpus ID: 3502408
To the Editor.— Recognition of the distinctive corneal opacity associated with amiodarone therapy has stimulated our interest in…
Expand
Highly Cited
1974
Highly Cited
1974
Ganglioside catabolism in hexosaminidase A-deficient adults
J. Tallman
,
R. Brady
,
R. Navon
,
B. Padeh
Nature
1974
Corpus ID: 4290817
TAY-SACHS disease is an inborn error of glycosphingolipid metabolism characterised by the accumulation of N-acetyl-galactosaminyl…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE